Faculty of Medicine, Main Univeristy Hospital
Alexandria, Egypt
NCT Number: NCT04744766
the study compares two surgical techniques in excision of the central duct system of the breast. known also as major duct excision
Looking for future studies?
Notify MeFemale
Interventional
Not applicable
Alexandria, Egypt
first technique used is the original Hadfield techniques. the other technique is Almasad technique published in 1999. in this technique, de-epithelialization of a supraareolar area of nearly 2cm is done and elevation of the nipple areola complex is done to support the retroareolar area.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
females with nipple discharge / recurrent peri-ductal mastitis
-
Exclusion criteria
2 methods of major/central mammary duct excision are compared as regard the outcome
Time frame: 6 months
cosmetic outcome assessed via score between non-satisfied -extremely satisfied sensation is assessed via acotton bad comaring both side or nearby skin
Time frame: 6 months
eg nipple areolae complex (NAC) sensation, necrosis...etc
Alexandria University
Other
Acronym: MDE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05364138
Benign Breast Disease, Breast Cancer
Butaro, Rwanda
View Trial DetailsNCT04258085
Benign Breast Disease, Breast Cancer
Kigali, Rwanda
View Trial DetailsNCT04131972
Benign Breast Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Pisa, Italy
View Trial DetailsNCT01160510
Benign Breast Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Burlington, Vermont, United States
View Trial Details